Acta Vet. Brno 2022, 91: 35-42
https://doi.org/10.2754/avb202291010035
Protein C activity in dogs with gastric dilatation and volvulus
References
1. KN, Burgener IA, Kovacevic A, Schulze SP, Kohn B 2009: Myoglobin as a prognostic indicator for outcome in dogs with gastric dilatation-volvulus. J Vet Emerg Crit Care 19: 247-253
<https://doi.org/10.1111/j.1476-4431.2009.00421.x>
2. JJ, Staatz AJ, Pelsue DH, Kudnig ST, MacPhail CM, Seim HB 3rd, Monnet E 2006: Risk factors associated with short-term outcome and development of perioperative complications in dogs undergoing surgery because of gastric dilatation-volvulus: 166 cases (1992-2003). J Am Vet Med Assoc 229: 1934-1939
<https://doi.org/10.2460/javma.229.12.1934>
3. JS 2014: Inherited and predisposing factors in the development of gastric dilatation volvulus in dogs. Top Companion Anim Med 29: 60-63
<https://doi.org/10.1053/j.tcam.2014.09.002>
4. KA, Syring RS, Drobatz KJ 2013: Evaluation of plasma lactate concentration and base excess at the time of hospital admission as predictors of gastric necrosis and outcome and correlation between those variables in dogs with gastric dilatation-volvulus: 78 cases (2004-2009). J Am Vet Med Assoc 242: 54-58
<https://doi.org/10.2460/javma.242.1.54>
5. JF, Marin N, Mignon A, Vinsonneau C 2001: Hepatic response to sepsis: Interaction between coagulation and inflammatory processes. Crit Care Med 29: 42-47
<https://doi.org/10.1097/00003246-200107001-00016>
6. AM, Freeman LM, Shaw SP, Brooks MB, Rozanski EA, Rush JE 2003: Hemostatic changes in dogs with naturally occurring sepsis. J Vet Intern Med 17: 674-679
<https://doi.org/10.1111/j.1939-1676.2003.tb02499.x>
7. AM, Rozanski EA, Freeman LM, Li W 2008: Serial evaluation of protein C and antithrombin in dogs with severe sepsis. J Vet Intern Med 22: 26-30
<https://doi.org/10.1111/j.1939-1676.2007.0021.x>
8. E, Drobatz KJ, Hughes D 1999: Plasma lactate concentration as a predictor of gastric necrosis and survival among dogs with gastric dilatation-volvulus: 102 cases (1995-1998). J Am Vet Med Assoc 215: 49-52
9. CJ, Yan SB 2000: Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med 28: 49-56
<https://doi.org/10.1097/00003246-200009001-00011>
10. LT, Lantz GC, Schellenberg DB, Glickman NW 1998: A prospective study of survival and recurrence following the acute gastric dilatation- volvulus syndrome in 136 dogs. J Am AnimHosp Assoc 34: 253-259
<https://doi.org/10.5326/15473317-34-3-253>
11. GC, Bottoms GD, Carlton WW, Newman S, Cantwell HD 1984: The effect of 360° gastric volvulus on the blood supply of the nondistended normal dog stomach. Vet Surg 13: 189-196
<https://doi.org/10.1111/j.1532-950X.1984.tb00787.x>
12. JA, García-Frade LJ, Landín L, de Pablo R, Torrado C, Renes E, García-Avello A. 1993: Time course of hemostatic abnormalities in sepsis and its relation to outcome. Chest 103: 1536-1542
<https://doi.org/10.1378/chest.103.5.1536>
13. G, Barnhart M, Kennedy S, DeHoff W, Schertel E 2010: A retrospective study of factors influencing survival following surgery for gastric dilatation-volvulus syndrome in 306 dogs. J Am Anim Hosp Assoc 46: 97-102
<https://doi.org/10.5326/0460097>
14. RM, Ward M, Marlar RA 1989: Protein C activity levels in endotoxin-induced disseminated intravascular coagulation in a dog model. Thromb Res 55: 297-307
<https://doi.org/10.1016/0049-3848(89)90062-5>
15. DL, Hauptman JG, Fulton RB Jr. 1993: Abnormal hemostatic profiles and gastric necrosis in canine gastric dilatation-volvulus. Vet Surg 22: 93-97
<https://doi.org/10.1111/j.1532-950X.1993.tb01680.x>
16. E, Raw C, Hughes D 2014: Plasma lactate concentration as a prognostic biomarker in dogs with gastric dilatation and volvulus. Top Companion Anim Med 29: 71-76
<https://doi.org/10.1053/j.tcam.2014.09.005>
17. CA 2002: Laparoscopic-assisted gastropexy. J Am Anim Hosp Assoc 38: 15-19
<https://doi.org/10.5326/0380015>
18. L, Vanova-Uhrikova I, Rehakova K 2020: Acid-base, electrolyte and lactate abnormalities as well as gastric necrosis and survival in dogs with gastric dilation-volvulus syndrome. A retrospective study in 75 dogs. Top Companion Anim Med 39: 100403
<https://doi.org/10.1016/j.tcam.2020.100403>
19. KK, Goldsmid SE, Lee J, Simpson DJ 2020: Retrospective analysis of 736 cases of canine gastric dilatation volvulus. Aust Vet J 98: 232-238
<https://doi.org/10.1111/avj.12942>
20. G, Dondi F, Grassato L, Magna L, Cola V, Giunti M, Del Magno S, Valentini S 2018: Prognostic value of canine pancreatic lipase immunoreactivity and lipase activity in dogs with gastric dilatation-volvulus. PLoS One 13: e0204216
<https://doi.org/10.1371/journal.pone.0204216>
21. I, Rauserova-Lexmaulova L, Rehakova K, Scheer P, Doubek J 2015: C-reactive protein and high mobility group box 1 in dogs with gastric dilatation and volvulus. J Vet Emerg Crit Care 25: 488-494
<https://doi.org/10.1111/vec.12324>
22. L, Crha M, Raušer P, Nečas A 2011: Clinical results and complications of preventive laparoscopic assisted gastropexy in 17 dogs: preliminary study. Acta Vet Brno 80: 93-99
<https://doi.org/10.2754/avb201180010093>
23. J, Moritz A, Kramer M, Bauer N 2015: Hemostatic variables, plasma lactate concentration, and inflammatory biomarkers in dogs with gastric dilatation-volvulus. Tierarztl Prax Ausg K Kleintiere Heimtiere 43: 389-398
24. SB, Dhainaut JF 2001: Activated protein C versus protein C in severe sepsis. Crit Care Med 29: 69-74
<https://doi.org/10.1097/00003246-200107001-00024>
25. J, Crha M, Lexmaulova L, Nečas A, Fichtel T 2005: Gastric dilatation-volvulus syndrome: outcome and factors associated with perioperative mortality. Acta Vet Brno 74: 621-631
<https://doi.org/10.2754/avb200574040621>

